Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuvan Research is a California-based longevity biotechnology company focused on developing therapies to reverse biological aging and promote tissue regeneration. The company's lead therapeutic candidate, E5, is a patent-pending, pig plasma-derived treatment containing extracellular nanoparticles and exosomes that has demonstrated significant biological age reversal and lifespan extension in rodent models. Additionally, Yuvan Research has commercialized NEEL Gel, a science-backed cosmetic skincare product formulated with the GHK-Cu copper peptide to stimulate collagen and elastin synthesis. Co-founded by Akshay Sanghavi and Dr. Harold Katcher, the company leverages epigenetic clocks and advanced biomarkers to validate its rejuvenation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuvan Research.